Carbamazepine-induced IgG1 and IgG2 deficiency associated with B cell maturation defect

Seizure

Volumn 13, Issue 3, 2004, Pages 187-190

  Go, Tohshin ^a  

^a TAKATSUKI RED CROSS HOSPITAL   (Japan)

Author keywords

B cell maturation defect; Carbamazepine; IgG deficiency; IgG subclasses deficiency; IgG1 deficiency; IgG2 deficiency

Indexed keywords

CARBAMAZEPINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN M; LYMPHOCYTE MEMBRANE IMMUNOGLOBULIN; MEMBRANE ANTIGEN; POLYSACCHARIDE;

ANTIBODY SPECIFICITY; ARTICLE; B LYMPHOCYTE; CASE REPORT; CELL MATURATION; CELL MEMBRANE; CELL SURFACE; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEFICIENCY; LABORATORY TEST; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SYMPTOMATOLOGY; TONIC SEIZURE; TURBIDIMETRY;

EID: 1642483746     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1059-1311(03)00086-4     Document Type: Article

References (15)

1. Castro, A. P., Redmershi, M. G., Pastorino, A. C., Paz, J. A., Fomin, A. B. and Jacob, C. M. Secondary hypogammaglobulinemia after use of carbamazepine: Case report and review. Revista do Hospital das Clinicas 2001; 56: 189-192.
2. Pacifici, R., Paris, L., Di Carlo, S., Pichini, S. and Zuccaro, P. Immunological aspects of carbamazepine treatment in epileptic patients. Epilepsia 1991; 32: 122-127.
3. Garcia Rodriguez, M. C., de la Concha, E. G., Fontan, G. et al. Transient hypogammaglobulinemia in the adult. Functional assessment of T and B lymphocytes. Journal of Clinical and Laboratory Immunology 1983; 11: 55-58.
4. Spickett, G. P., Gompels, M. M. and Saunders, P. W. G. Hypogammaglobulinemia with absent B lymphocytes and agranulocytosis after carbamazepine treatment. Journal of Neurology, Neurosurgery, and Psychiatry 1996; 60: 459-462.
5. Van Ginneken, E. E., van der Meer, J. W. and Netten, P. M. A man with a mysterious hypogammaglobulinemia and skin rash. The Netherlands Journal of Medicine 1999; 54: 158-162.
6. Voutsinas, D., Foudoulaki, L., Sofroniadou, K. and Galanakis, N. Visceral leishmaniasis in a patient with acquired hypogammaglobulinemia. European Journal of Internal Medicine 2001; 12: 127-129.
7. Hayashibara, H., Tanimoto, K., Nagata, I., Harada, Y. and Shiraki, K. Normal levels of IgG subclass in childhood determined at a sensitive ELISA. Acta Paediatrica Japonica 1993; 35: 113-117.
8. Kojima, K., Ishizka, A., Oshika, E. et al. Quantitation of IgG subclass antibodies to pneumococcal capsular polysaccharides by ELISA, using Pneumovax-specific antibodies as a reference. Tohoku Journal of Experimental Medicine 1990; 161: 209-215.
9. Strandjord, R. E., Johannessen, S. I. and Aarli, J. A. Serum concentrations of immunoglobulins in patients with epilepsy treated with carbamazepine. Acta Neurologica Scandinavica 1980; 61: 260-263.
10. Bostantjopoulou, S., Hatzizisi, O., Argyropoulou, O. et al. Immunological parameters in patients with epilepsy. Functional Neurology 1994; 9: 11-15.
11. Gilhus, N. E. and Matre, R. Carbamazepine effects on mononuclear blood cells in epileptic patients. Acta Neurologica Scandinavica 1986; 74: 181-185.
12. Sommer, R., Rittmannsgerger, H., Stöbich, E., Kainz, Ch. and Leblhuber, F. Monitoring of laboratory parameters during carbamazepine therapy in psychiatric patients. Pharmacopsychiatry 1992; 25: 150-153.
13. Basaran, N., Hincal, F., Kansu, E. and Ciger, A. Humoral and cellular immune parameters in untreated and phenytoin- or carbamazepine-treated epileptic patients. International Journal of Immunopharmacology 1994; 16: 1071-1077.
14. Marcoli, M., Gatti, G., Ippoliti, G. et al. Effect of chronic anticonvulsant monotherapy on lymphocyte subpopulations in adult epileptic patients. Human Toxicology 1985; 4: 147-157.
15. Gilhus, N. E. and Lea, T. Carbamazepine: Effect on IgG subclass in epileptic patients. Epilepsia 1988; 29: 317-320.